- Multivariate test that identifies the chronic elevation of acute phase reactants, which are known to be associated with aggressive cancer
- Impacts treatment strategy and facilitates disease state monitoring
Top-down proteomics approach for analyzing intact proteins in serum and plasma.
We have developed the DeepMALDI® system, a proprietary high-density matrix-assisted laser desorption/ionization time-of-flight (MALDI-ToF) mass spectrometry (MS) technology, to help overcome the limitations of conventional MALDI-ToF and other mass spectrometry methods by producing highly sensitive, stable, and reproducible data best suited for the discovery of diagnostic tests with clinical utility.
* The images on our site are not representative of the Biodesix lab during COVID-19.